NUVA - ニュ―ベイシブ (NuVasive Inc.) ニュ―ベイシブ

 NUVAのチャート


 NUVAの企業情報

symbol NUVA
会社名 Nuvasive Inc (ニュ―ベイシブ)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical/Dental Instruments  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 ニュベーシブ(NuVasive Inc)は医療機器会社である。同社は、最小限の破壊的外科用製品の開発と、背骨手術のための手続き型統合ソリューションの開発に集中する。同社の製品ポートフォリオは、脊椎固定術を補助するために使用される生物製剤を含む脊椎固定手術のアプリケーションに重点を置く。主力製品には、最大アクセス外科手術(MAS)と呼ばれる最小限の破壊的手術プラットフォームが含まれる。このプラットフォームには、NVM5を含むソフトウェア駆動の神経検出および回避システム、術中モニタリングサービスおよびサポート、統合スプリットブレードレトラクタシステムであるMaXcess、及び各種インプラント、バイオロジックが含まれる。このプラットフォームは、MaXcessリトラクタ、特殊インプラントおよび固定製品、外科医が神経を検出してナビゲートすることを総合的に可能にするインプラント送達のためのスパインへのカスタマイズされたアクセスを指示する3つの製品カテゴリを組み合わせている。   ニュ―ベイシブは米国の医療機器メ―カ―。整形外科領域の脊椎外科向けインプラント、神経モニタ―リング機器などの開発、製造、リ―ス、修理、設置・取り付け、調査研究、販売を行う。米国以外の拠点はプエルトリコ、英国、ドイツ、オ―ストラリア、シンガポ―ル、日本など。本社はカリフォルニア州。   NuVasive, Inc. is the leader in spine technology innovation, focused on transforming spine surgery and beyond with minimally disruptive, procedurally integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings. With over $1 billion in revenues, NuVasive has an approximate 2,400-person workforce in more than 40 countries serving surgeons, hospitals and patients.
本社所在地 7475 Lusk Boulevard San Diego CA 92121 USA
代表者氏名 Gregory T. Lucier グレゴリー・T・ルシエ
代表者役職名 Chairman of the Board Chief Executive Officer 取締役会長兼最高経営責任者
電話番号 +1 858-909-1800
設立年月日 35612
市場名 NASDAQ National Market System
ipoyear 2004年
従業員数 2600人
url www.nuvasive.com
nasdaq_url https://www.nasdaq.com/symbol/nuva
adr_tso
EBITDA EBITDA(百万ドル) 238.77000
終値(lastsale) 69.67
時価総額(marketcap) 3582601952.16
時価総額 時価総額(百万ドル) 3190.763
売上高 売上高(百万ドル) 161.169
企業価値(EV) 企業価値(EV)(百万ドル) 3750.266
当期純利益 当期純利益(百万ドル) 22.43600
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 NuVasive Inc. revenues increased 7% to $542.1M. Net loss totaled $15.6M vs. income of $24.6M. Revenues reflect International (excludes Puerto Rico) segment increase of 29% to $101.8M United States segment increase of 3% to $440.3M. Net loss reflects Litigation liability (gain) loss increase from $0K to $27.8M (expense) Sales Marketing increase of 7% to $283M (expense).

 NUVAのテクニカル分析


 NUVAのニュース

   VNDA On Watch, NUVA Q2 Results Miss Estimates, MRTX Awaits FDA Decision...  2022/08/04 09:25:05 RTT News
NuVasive Inc. (NUVA), a company focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, has reported lower-than-expected earnings and sales for the second quarter of 2022.
   NuVasive, Inc. (NUVA) CEO Chris Barry on Q2 2022 Results - Earnings Call Transcript  2022/08/04 01:37:12 Seeking Alpha
NuVasive, Inc. (NASDAQ:NASDAQ:NUVA) Q2 2022 Earnings Conference Call August 3, 2022 4:30 PM ET Company Participants Juliet Cunningham – Vice President-Investor Relations Chris Barry – Chief…
   NuVasive, Inc. 2022 Q2 - Results - Earnings Call Presentation (NASDAQ:NUVA)  2022/08/03 22:37:12 Seeking Alpha
The following slide deck was published by NuVasive, Inc.
   Recap: NuVasive Q2 Earnings  2022/08/03 20:44:53 Benzinga
NuVasive (NASDAQ: NUVA ) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here''s what investors need to know about the announcement. Earnings NuVasive missed estimated earnings by 16.07%, reporting an EPS of $0.47 versus an … Full story available on Benzinga.com
   NuVasive, Inc. Q2 Earnings Summary  2022/08/03 20:40:00 Finanz Nachrichten
WASHINGTON (dpa-AFX) - Below are the earnings highlights for NuVasive, Inc. (NUVA):Earnings: -$0.89 million in Q2 vs. $1.80 million in the same period last year. EPS: -$0.02 in Q2 vs. $0.03 in the…
   NuVasive Opens Singapore Experience Center for Asia-Pacific region  2022/06/29 20:10:00 PR Newswire
New center supports the Company''s globalization efforts through increased surgeon training and education in Asia-Pacific region SAN DIEGO, June 29, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with…
   NuVasive: Industry Tailwinds More Than Fairly Priced  2022/06/13 10:40:56 Seeking Alpha
NuVasive (NUVA) has solid underpinnings as a potentially defensive play. See why I think NUVA stock may be fully priced at its current levels.
   Spine Implants Global Market Report 2022  2022/05/26 12:48:00 GlobeNewswire
Major players in the spine implants market are Medtronic, Depuy Synthes, Johnson & Johnson, Stryker Corporation, NuVasive, Inc. , Zimmer Biomet Holdings, Globus Medical, Alphatec Holdings, Orthofix International, and RTI Surgical. Major players in the spine implants market are Medtronic, Depuy Synthes, Johnson & Johnson, Stryker Corporation, NuVasive, Inc. , Zimmer Biomet Holdings, Globus Medical, Alphatec Holdings, Orthofix International, and RTI Surgical.
   Orthopedic Accessories Global Market Report 2022  2022/05/13 08:24:00 GlobeNewswire
Major players in the orthopedic accessories devices (or) equipment market are Stryker Corporation, Zimmer-Biomet Holding, DePuy Synthes, Smith and Nephew PLC, McDavid, Aesculap Implant System, Conmed Corporation, Donjoy, NuVasive, and Medtronic PLC. Major players in the orthopedic accessories devices (or) equipment market are Stryker Corporation, Zimmer-Biomet Holding, DePuy Synthes, Smith and Nephew PLC, McDavid, Aesculap Implant System, Conmed Corporation, Donjoy, NuVasive, and Medtronic PLC.
   NuVasive, Inc. (NUVA) CEO Chris Barry on Q1 2022 Earnings Call Transcript  2022/05/05 02:01:04 Seeking Alpha
NuVasive, Inc. (NASDAQ:NASDAQ:NUVA) Q1 2022 Earnings Conference Call May 04, 2022 04:30 PM ET Company Participants Juliet Cunningham - VP, IR Chris Barry - CEO Matt Harbaugh - CFO…
   The Daily Biotech Pulse: Sarepta Gene Therapy Data, Idera Plunges On Failed Skin Cancer Study, 3 IPOs  2021/03/19 11:46:46 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 18) AngioDynamics, Inc. (NASDAQ: ANGO ) Anixa Biosciences, Inc. (NASDAQ: ANIX ) ENDRA Life Sciences Inc. (NASDAQ: NDRA ) (announced a collaboration with Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA ) for NASH studies) Harvard Bioscience, Inc. (NASDAQ: HBIO ) Neos Therapeutics, Inc. (NASDAQ: NEOS ) (reacted to the shareholder meeting held to vote on the proposal to merge with Aytu BioScience, Inc. (NASDAQ: AYTU )) NuVasive, Inc. (NASDAQ: NUVA ) SI-BONE, Inc. (NASDAQ: SIBN ) Sierra Oncology, Inc. (NASDAQ: SRRA ) Silverback Therapeutics, Inc. (NASDAQ: SBTX ) Terns Pharmaceuticals, Inc. (NASDAQ: TERN ) Varian Medical Systems, Inc. (NASDAQ: VAR ) Vericel Corporation (NASDAQ: VCEL ) Vincerx Pharma, Inc. (NASDAQ: VINC ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows March 18) Foghorn Therapeutics Inc. (NASDAQ: FHTX ) (issued a corporate update) Galecto, Inc. (NASDAQ: GLTO ) Voyager Therapeutics, Inc. (NASDAQ: VYGR ) Stocks In Focus Sarepta Presents Positive Data For Gene Therapy to Treat Limb-gridle Muscular Dystrophy Sarepta Therapeutics, Inc. (NASDAQ: SRPT ) announced new results from the ongoing study of SRP-9003, its investigational gene therapy for limb-girdle muscular dystrophy Type 2E, showing sustained protein expression in muscle tissue.
   The Daily Biotech Pulse: Translate Bio's Cystic Fibrosis Study Disappoints, Adverum Nominates Directors, Gain Therapeutics To Debut On Nasdaq  2021/03/18 12:16:32 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 17) AngioDynamics, Inc. (NASDAQ: ANGO ) Anixa Biosciences, Inc. (NASDAQ: ANIX ) BioAtla, Inc. (NASDAQ: BCAB ) Harvard Bioscience, Inc. (NASDAQ: HBIO ) IDEAYA Biosciences, Inc. (NASDAQ: IDYA ) Immatics N.V. (NASDAQ: IMTX ) ( announced positive Phase 1 readout for a trio of candidates in solid tumors) NGM Biopharmaceuticals, Inc. (NASDAQ: NGM ) NuVasive, Inc. (NASDAQ: NUVA ) Omnicell, Inc. (NASDAQ: OMCL ) Oncternal Therapeutics, Inc. (NASDAQ: ONCT ) Organogenesis Holdings Inc. (NASDAQ: ORGO ) PLx Pharma Inc. (NASDAQ: PLXP ) Sierra Oncology, Inc. (NASDAQ: SRRA ) Silverback Therapeutics, Inc. (NASDAQ: SBTX ) STRATA Skin Sciences, Inc. (NASDAQ: SSKN ) Urovant Sciences Ltd. (NASDAQ: UROV ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows March 17) Foghorn Therapeutics Inc. (NASDAQ: FHTX ) Galapagos NV (NASDAQ: GLPG ) Galecto, Inc. (NASDAQ: GLTO ) Stocks In Focus Translate Bio mRNA Product Candidate For Cystic Fibrosis Fails To Improve Lung Function In Phase 1/2 Study Translate Bio (NASDAQ: TBIO ) announced a second interim analysis from the Phase 1/2 study of MRT5005 in patients with cystic fibrosis, showing that repeat dosing was generally safe and well tolerated, with no serious adverse events.
   NuVasive and the International Spine Study Group Foundation Announce Expanded Long-Term Partnership with Initiation of Additional Clinical Studies  2021/03/16 12:33:00 PR Newswire
SAN DIEGO, March 16, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, and the International Spine Study Group Foundation (ISSGF) today…
   Active Implantable Medical Devices Market 2021 - 2027 Size, Industry Share, Growth, COVID-19 Analysis, Top Key Players : Boston Scientific Corporation, Biotronik, LivaNova PLC, Globus Medical, Inc., NuVasive  2021/03/16 12:07:43 OpenPR
Rise in prevalence of chronic diseases, supportive initiatives from medical health insurance companies for critical issues, and increase in awareness regarding different types of implants drive the growth of the global medical implant market. However, high cost of treatment and
   Biological Implants Market will touch a new level in upcoming year with top key players like Integra LifeSciences Corporation, NuVasive Inc, Edward LifeSciences Corporation - The Courier  2021/03/01 15:37:02 The Courier
This report gives a detailed and comprehensive understanding of Biological Implants market. With precise data covering all key aspects of the existing

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 ニュ―ベイシブ NUVA NuVasive Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)